Vol.

No.

October 20, 2023Oct 20, 2023

DOWNLOAD THE PDF

Mark Evers tells us how Markey went from Cancer Center to Comprehensive designation in 10 years

Cover Story

Conversation with The Cancer Letter

Mark Evers tells us how Markey went from Cancer Center to Comprehensive designation in 10 years

By Paul Goldberg

The University of Kentucky Markey Cancer Center received NCI’s Comprehensive designation just 10 whip-fast years after the center received its initial Cancer Center designation.

Capitol Hill

At Senate confirmation hearing for NIH directorship, Bertagnolli focuses on clinical trials, data analytics, health equity

By Alexandria Carolan

Capitol Hill

House oversight committee threatens to subpoena NIH documents in sexual misconduct investigation

By Matthew Bin Han Ong

Free Obituary

Franklyn Prendergast, first Black director of an NCI-designated cancer center, was a role model to minority physicians

By Otis W. Brawley and Robert A. Winn

Free Obituary

Mayo’s Franklyn Prendergast dies at 78

By Audrey Laine Seymour

Free In the Archives

Remembering Franklyn Prendergast: His 2021 Mayo Clinic commencement speech

In Brief

Joann Sweasy named director of University of Nebraska cancer center

The Mark Foundation awards $12M in Endeavor grants to four teams for collaborative projects

Vanderbilt-Ingram earns NCI Merit Award

Siteman receives $10.9M SPORE grant for pancreatic cancer research

Xiang Zhang named director of Smith Breast Center at Baylor

Fred Hutch names eight recipients of 2023 Dr. Eddie Méndez Scholar Award

Igor Astsaturov appointed inaugural Paul F. Engstrom Professor in Oncology at Fox Chase

Roswell Park to open $98M cell and gene therapy manufacturing facility

Rady Children’s oncologist Paula Aristizabal receives $4M to diversify clinical trials participation

Jinglei Ping receives $1.9M NIH grant to investigate cell communication

Sylvester, DFCI researchers receives $4M NCI grant to study whether lifestyle interventions can benefit patients with advanced breast cancer

Stephen D. Nimer named “Researcher of the Year” by BioFlorida

Dean Stoios named chief financial officer at Wistar

Purdue names new pediatric cancer research center for the late Tyler Trent

MDsave offers discounted mammograms during Breast Cancer Awareness Month

Clinical Roundup

Perioperative Opdivo-based regimen shows significant improvement in EFS for resectable NSCLC

MRI scan could predict radiation side effects for prostate cancer

UC, UNC, Duke to collaborate on large prospective study investigating effect of cancer on stroke risk

Novel cancer therapy target stops tumor cells from sharing resources in preclinical models

Drugs & Targets

FDA approves neoadjuvant/ adjuvant Keytruda for resectable NSCLC

FDA approves nivolumab for adjuvant treatment of stage 2B/C melanoma

EC approves Keytruda as adjuvant treatment for NSCLC at high risk of recurrence

CHMP issues positive opinion for Keytruda + chemo as first-line treatment for HER2-negative, PD-L1-positive advanced gastric or GEJ cancer

EC approves Adcetris for adults with stage 3 Hodgkin lymphoma

CHMP issues positive opinion for Rubraca as a first-line maintenance treatment for advanced ovarian cancer

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 45 - December 06, 2024